Anavex Life Sciences Corp (AVXL)

[nidan7500]

https://ghr.nlm.nih.gov/primer/precisionmedicine/definition

Precision Medicine and the street? CNS disease complexity? Now What?

Now that the established research models for how to invest in CNS treatment Pharma have been nuked what are the street investors going to do? The IPO float/scam guys have to re-tool. Sad isn't it? BP's exclusive hold on max (n) trials w/massive $$$ WW sites and secret handshakes is ALL GONE. A game that only the privileged few could afford.

As far as we know, Dr. M. has been on the ("NO REALLY", FIND OUT WHAT CAUSES IT) trail for a few years now, while the rest of them were redefining their statistical model rationalizations. Then some fool in Oncology started a new process concept and (what do you know) it worked. (much to the concern of the toxic chemical/radiation bombardment crowd).

Precision medicine suggests the clinicians spend time to actually research what gut genom/environmental/other causa links exist. Then, after narrowing the chase, target specific patients based on science, not shot-gunning. The questions then become not "IF" the treatment works at all but "How on many patients". Ensure the study presents evidence of efficacy? Not IF but WHEN.

Will the STREET systems actually allow such investments to even happen or will they be compelled to JUST GO BUY or ATTACK?

We'll see. In my opinion, that kind of process is what we will see. How will it play out, what will it look like? Look for change everywhere. As Musashi would say, "the Pen and the sword, in accord."

Not clear how we will know who is on first in this new model, we can say that change is happening though. The FDA should lead but I doubt they will. The good news is, the bad old days in CNS disease treatment development/research are likely gone. Change cannot be too soon for many.